Immunotherapeutics against cancer and infectious diseases

ISA Pharmaceuticals B.V. is developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections.

News

May 23, 2017
Updated Results of Cervical Cancer Study Sponsored by ISA Pharmaceuticals to Be Presented at ASCO 2017
May 11, 2017
ISA Pharmaceuticals´ Chief Scientific Officer Prof. Cornelis Melief Honored by the Association for Cancer Immunotherapy (CIMT)

Events

September 6 – 9, 2017
Third CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

Latest Publications

September 5, 2016
Cancer Research / Science Translational Medicine
Cancer Research / Science Translational Medicine

More news

More events

More publications

Loading Quotes...